Latest in News & Research
No Evidence That Live Vaccines Are Unsafe for Patients on Dupilumab
Systematic review shows vaccine efficacy not affected by dupilumab in general
Worst Itch Numeric Rating Scale Can Assess Itch in Prurigo Nodularis
Moderate-to-strong correlations support convergent validity; rating scale sensitive to change
Study Identifies Characteristics of Melanomas in Giant Pigmented Nevi
MGPN diagnoses occur at younger age than other melanomas; disease-specific, overall survival rates comparable to other melanomas
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma
Neoadjuvant treatment followed by surgery results in longer event-free survival for resectable, macroscopic stage III melanoma
Risk for cSCC Metastases Increased for Solid Organ Transplant Recipients
Risk factors for metastases include location in head and neck area, local recurrence, size >2 cm, clinical ulceration
Dietary Sodium Intake May Affect Risk of Atopic Dermatitis
Increased odds of AD, active AD, increasing severity of AD seen with 1-g increase in estimated 24-hour urine sodium excretion
1.5 Percent Ruxolitinib Cream Safe, Effective for Teens With Eczema
Ruxolitinib cream well tolerated, and disease control maintained over a year with as-needed use
The 40-gene expression profile (40-GEP) test identifies cutaneous squamous cell carcinoma (cSCC) patients at high risk of metastasis within lower-staged tumors to better guide treatment decisions
At the 2024 Fall Clinical Dermatology Conference for PAs and NPs, Ally-Khan Somani, MD, PhD, and co-authors presented a poster on their study utilizing...
Bimekizumab Yields Meaningful Response in Hidradenitis Suppurativa
Rapid clinically meaningful response seen, which was maintained for 48 weeks for moderate-to-severe hidradenitis suppurativa
Parental E-Cigarette Use Linked to Increase in Pediatric Atopic Dermatitis
Increased odds of atopic dermatitis seen for children with parental e-cigarette use, regardless of parent sex
Tapinarof Efficacious, Safe for Pediatric, Adult Patients With Eczema
Significantly more eczema patients who received tapinarof met primary efficacy end point at week 8
15.3 Percent With Melanoma Have Germline Likely/Pathogenic Variants
67 percent are in genes considered unrelated to melanoma
Antihypertensives Linked to Eczematous Dermatitis in Seniors
Largest effect sizes seen for diuretics and calcium channel blockers, smallest for ACE inhibitors, β-blockers
Industry Payments Per Dermatologist Have Increased Since 2015
Average annual percentage change increased for number of recipient dermatologists, total value of payments
Little or No Increased Risk for Skin Cancer Seen for Women With BRCA Mutations
No increased risk for nonmelanoma skin cancer observed, but risk for melanoma slightly elevated
Acrochordons May Be Marker for Metabolic Disease in Children
Prevalence of obesity, type 2 diabetes, hyperlipidemia, hypertension greater in children with acrochordons versus NHANES
Individuals With BAP1 Have High Rate of Nail Abnormalities
Almost all patients with nail involvement had polydactylous involvement with onychopapillomas
Poorer Survival Outcomes Seen for Head and Neck Merkel Cell Carcinoma
Risk for death significantly increased for head and neck MCC compared with other body regions
Dupilumab Beneficial for Patients With Hand, Foot Atopic Dermatitis
Significantly more patients achieved Hand and Foot Investigator's Global Assessment score of 0 or 1
Non-Hispanic Black Melanoma Patients Present With Advanced Disease
T category and stage at presentation higher for non-Hispanic Black patients
Coexistence of Psoriatic Arthritis, Atopic Dermatitis May Offer Treatment Insights
One-third of psoriatic arthritis patients have atopic diseases, most often dermatitis versus atopic rhinitis and allergic asthma
Systemic Antibiotics in First Year of Life Tied to Higher Atopic Dermatitis Risk
Dose-response relationship seen for number of antibiotic courses and atopic dermatitis risk
Trifarotene Plus Skin Care Beneficial for Acne Vulgaris
Improvement seen in acne-induced hyperpigmentation overall disease severity score at week 12, but not week 24
24 of 1244